ROLANDA VONKURNATOWSKI: Open Payments
NPI 1952177370 · DENHAM SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Amgen Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: CAMZYOS, Kerendia, VERQUVO, NEXLETOL, REPATHA, WATCHMAN FLX, FUROSCIX, Wegovy.
Industry payments across LA — which companies pay providers there.
